VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 112 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,627 | -33.0% | 20,468 | -33.3% | 0.00% | -100.0% |
| Q1 2023 | $236,728 | +84.1% | 30,704 | +45.7% | 0.00% | – |
| Q4 2022 | $128,570 | -18.1% | 21,077 | +2.3% | 0.00% | -100.0% |
| Q1 2022 | $157,000 | +93.8% | 20,602 | +19.8% | 0.00% | – |
| Q1 2021 | $81,000 | -90.8% | 17,200 | -86.1% | 0.00% | -100.0% |
| Q4 2020 | $882,000 | -32.7% | 123,360 | +0.4% | 0.00% | -20.0% |
| Q3 2020 | $1,311,000 | -16.9% | 122,860 | -1.7% | 0.01% | -37.5% |
| Q2 2020 | $1,577,000 | +25.9% | 124,960 | -8.7% | 0.01% | 0.0% |
| Q1 2020 | $1,253,000 | -23.9% | 136,938 | +16.1% | 0.01% | +60.0% |
| Q4 2019 | $1,646,000 | +43.1% | 117,963 | +76.6% | 0.01% | +25.0% |
| Q3 2019 | $1,150,000 | +995.2% | 66,800 | +499.6% | 0.00% | – |
| Q4 2018 | $105,000 | -57.1% | 11,141 | -13.9% | 0.00% | -100.0% |
| Q3 2018 | $245,000 | – | 12,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |